In: Finance
Brent Bush, CFO of a medical device manufacturer, BioTron Medical, Inc., was approached by a Japanese customer, Numata, with a proposal to pay cash (in yen) for its typical orders of ¥15,000,000 every other month if it were given a 2.0% discount. Numata's current terms are 30 days with no discounts. Using the following quotes and estimated cost of capital for Numata, Bush will compare the proposal with covering yen payments with forward contracts. | ||
Spot rate, ¥/$ | ¥111.40/$ | |
30-day forward rate, ¥/$ | ¥115.00/$ | |
90-day forward rate, ¥/$ | ¥116.40/$ | |
180-day forward rate, ¥/$ | ¥117.20/$ | |
Numata's WACC | 10.000% | |
BioTron Medical's WACC | 12.000% |
$131,957.
$147,000
Yen14,700,000
Yen131,957.
Answer : $131957
(1). Allow the discount and receive payment in Japanese yen in cash
Assumptions | Values |
BioTron's 30-day account receivable, Japanese yen | ¥15,000,000 |
Spot rate, ¥/$ | ¥111.40/$ |
30-day forward rate, ¥/$ | ¥115.00/$ |
90-day forward rate, ¥/$ | ¥116.40/$ |
180-day forward rate, ¥/$ | ¥117.20/$ |
Numata's WACC | 10.000% |
BioTron Medical's WACC | 12.000% |
Desired discount on purchase price by Numata | 2.0% |
Calculation of discount and receive payment in Japanese yen in cash
Account recievable (yen) | ¥15,000,000 | |
Discount for cash payment up-front (2.0%) | (3,00,000) | |
Amount paid in cash net of discount | ¥14,700,000 | |
Current spot rate | 111.40 | |
Amount received in U.S. dollars by Seattle Scientific | $131957 | (¥14700000/111.40) |